###begin article-title 0
Interleukin-1 Beta -511 Polymorphism and Risk of Cervical Cancer
###end article-title 0
###begin p 1
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 577 581 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1052 1053 1046 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1221 1225 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 66 86 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 681 686 <span type="species:ncbi:9606">women</span>
Cervical cancer is almost invariably associated with infection by human papillomavirus. It is believed that the host genetic factors such as inflammation-induced cytokines may play a role in cervical carcinogenesis. The IL1B gene, encoding IL-1beta cytokine, contains several single nucleotide polymorphisms. One of them which is in the positions -511 (C-T) related with promoter region has been associated with increased IL-1beta production and with increased risk of developing a number of inflammatory diseases and gastric carcinoma. We assessed the association between the IL1B -511 polymorphism and cervical cancer risk in a hospital-based case-control study among 546 Korean women (182 cases; 364 age-matched controls). The allele frequencies of the case subjects (C, 0.42; T, 0.58) were not significantly different from those of control subjects (C, 0.43; T, 0.57). Control subjects were in Hardy-Weinberg equilibrium. The carriers with -511 C/T or T/T genotypes were at higher risk of cervical cancer with odds ratio of 2.42 (95% CI 1.31-4.46, p<0.005). However, there was no difference of cervical cancer risk between C/T heterologous genotypes and T/T homologous genotypes. In conclusion, in Korean population, IL1B -511 C/C genotypes were significantly associated with a decreased risk of cervical cancer.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 73 78 <span type="species:ncbi:9606">women</span>
###xml 202 222 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 224 227 <span type="species:ncbi:10566">HPV</span>
###xml 317 322 <span type="species:ncbi:9606">women</span>
###xml 360 363 <span type="species:ncbi:10566">HPV</span>
###xml 391 396 <span type="species:ncbi:9606">women</span>
Cervical cancer is the second major cause of cancer-related mortality in women worldwide and accounts for 250,000 deaths each year (1). It is well established that the infection with high-risk types of human papillomavirus (HPV) plays a central role in the pathogenesis of invasive cervical cancer (2). Although many women are infected with high-risk types of HPV, only a subset of infected women develops cervical cancer, suggesting that other cofactors including host genetic factors must be present for the development of malignancy.
###end p 3
###begin p 4
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
Chronic inflammation has been shown to be an important risk factor for a variety of epithelial cancers (3). Cytokines, as the products of host response to inflammation, play an important role in the defense against viral infections. In cervical cancers, a number of previous reports suggested that chronic inflammation is associated with the precancerous intraepithelial lesion and cancer of uterine cervix (4-6).
###end p 4
###begin p 5
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 592 596 592 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 691 695 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 739 740 739 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 830 834 830 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 922 926 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 951 955 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1029 1033 1029 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1093 1097 1093 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1130 1132 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1228 1232 1228 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 724 729 <span type="species:ncbi:9606">human</span>
The interleukin-1 family of cytokines consists of several members including ineterleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist. The genes for these cytokines are clustered within a 430-kb segment on human chromosome 2. These cytokines are produced by several cell types and have multiple biological effects. Interleukin-1 beta is a pro-inflammatory cytokine mainly produced by blood monocytes and tissue macrophages and has been implicated in mediating both acute and chronic inflammation (7). Recently, a common polymorphic allele of the regulatory region of the IL1B gene was found to be associated with increased IL-1 production (8). Also, the polymorphism in IL1B was associated with various human cancers (8-11). Since there were several reports supporting the positive association with increased IL1B secretion and cervical cancer risk (12, 13), we hypothesized that an individual with a IL1B genotype producing more IL1B might have an increased risk of cervical cancer. The C>T polymorphism in IL1B -511 site has been correlated with increased intracellular IL1B levels in the previous reports (14). Here we report results from a hospital based case-control study examining the association of IL1B -511 C>T polymorphisms with the risk of cervical cancer.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Subjects
###end title 7
###begin p 8
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
Case subjects were selected from among cervical cancer patients treated between April 1996 and July 2002 at the Seoul National University Hospital. A total of 182 patients with confirmed cervical squamous cell carcinoma consented to participate in the study and provided a blood specimen. Age-matched (1:2) control subjects were comprised of 364 healthy, unrelated, cancer-free subjects recruited from visitors who attended a comprehensive screening clinic at the same institution and agreed to participate in this study. Informed consent was received from all the cases and controls. All case and control subjects were Korean, and the Institutional Review Board of Seoul National University Hospital approved the protocol used in this study.
###end p 8
###begin title 9
Genotyping
###end title 9
###begin p 10
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 353 356 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
###xml 480 481 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 618 621 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 943 946 931 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
All genotyping of 182 cases and 364 control samples was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In brief, IL1B -511 C>T polymorphism was distinguished by PCR-RFLP, using the known primer pairs (forward primers 5'-GCCTGAACCCTGCATACCGT; reverse primers 5'GCCAATAGCCCTCCCTGTCT-3') and restriction enzyme AvaI. Amplification was performed in a volume of 25 microL, containing 2.5 microL of 10xPCR buffer (100 mM Tris-HCI, 15 mM MgCl2, and 500 mM KCl, pH 8.3), 200 nM each dNTP (Roche Diagnostics Korea, Seoul, Korea), 1 microM each primer (Bioneer, Daejeon, Korea), 1 U Taq DNA polymerase (Roche Diagnostics Korea, or Takara Shuzo, Otsu, Japan), and 100 ng of genomic DNA. The thermocycling conditions were as follows: 95℃ for 5 min; then 35 cycles of 95℃ for 30 sec, 58-60℃ for 30 sec, and 72℃ for 1 min; then 72℃ for 10 min. Fifteen microliters of the reaction mixture was treated with 5 U of AvaI (NE Biolabs, Beverly, MA, U.S.A.) at 37℃ for 12 hr and subsequently analyzed on 3% agarose (2% Nusieve [Bio-Whittaker Molecular Applications, Rockland, ME, U.S.A.] and 1% agarose) gel.
###end p 10
###begin title 11
Statistical analysis
###end title 11
###begin p 12
Hardy-Weinberg equilibrium analyses were performed to compare observed and expected genotype frequencies using the chi-square test (D.F.=1). Allele frequency differences between cases and controls were analyzed using the Pearson chi-square test. Cervical cancer risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs) using conditional logistic regression model after adjustment for age.
###end p 12
###begin title 13
RESULTS
###end title 13
###begin p 14
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
In Korean population, we observed that the allelic frequencies of the 182 case subjects (C, 0.42; T, 0.58) were not significantly different from those of the 364 control subjects (C, 0.43; T, 0.57). The allelic frequencies of control subjects were not statistically different from those reported for Korean populations by other investigators (9). The alleles were in Hardy-Weinberg equilibrium only in control subjects.
###end p 14
###begin p 15
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 195 202 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
We found that carriers of the T allele had a significantly increased risk of cervical cancer. The frequency distribution of the different genotypes for the IL1B -511 C>T polymorphism is shown in Table 1. The CC genotype was less frequent among the case subjects than among the control subjects (7.7% and 16.8%, respectively). With the use of the chi-square test, we found the significant difference in genotype frequencies between case and control subjects (p<0.001).
###end p 15
###begin p 16
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Using the CC genotype as the reference genotype, we performed logistic regression analysis with adjustment for age variable. The CT genotype was associated with significantly elevated OR of 2.83 (95% CI=1.52 to 5.28, p<0.001). Also, the TT genotype was associated with elevated OR of 1.68 (95% CI=0.85 to 3.32, p=0.136). When we combined CT and TT genotypes together, we found that CT and TT genotypes were associated with OR of 2.42 (95% CI=1.31 to 4.46, p<0.005).
###end p 16
###begin title 17
DISCUSSION
###end title 17
###begin p 18
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
Here we reported that -511 polymorphism in IL1B gene was associated with the risk of cervical cancer. Our findings in this hospital-based case-control study suggest that the carriers of -511 T allele may be at increased risk of developing cervical cancer. Our results support the previous hypothesis that -511 T allele is associated with increased production of IL-1beta, and that IL-1beta may play a role as host factors promoting cervical carcinogenesis.
###end p 18
###begin p 19
###xml 314 316 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 487 489 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 586 588 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 84 87 <span type="species:ncbi:10566">HPV</span>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
Since it is assumed that the host immune system is important in the surveillance of HPV-related cervical neoplasia, cytokines, including IL-1beta, have been frequently correlated to a risk of cervical cancer. The level of the IL-1beta was increased in the cervicovaginal washings of patients with cervical cancer (13). Individuals with high and intermediate IL-1beta secretor phenotypes may be more susceptible to lower grade lesions rather than high grade lesion or cervical carcinoma (12). Elevated vaginal lavage IL-1beta was associated with a high odds ratio of cervical dysplasia (15). These evidences, including the results of this study, suggest that IL-1beta may be involved in early step of cervical carcinogenesis and that individual difference of IL-1beta secretion may affect individual susceptibility to cervical cancer progression.
###end p 19
###begin p 20
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 276 282 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 716 720 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 978 982 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1087 1088 1087 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
The polymorphism of IL1B gene was reported to be associated with various diseases including cancer, but it is most intensively studied in gastric cancer. El-Omar et al. have recently reported that proinflammatory genotypes of the interleukin-1 gene cluster (IL1B -511/-31 and IL-1RN*2/*2) were associated with increased risk of gastric cancer and its presumptive precursors, gastric atrophy and hypochlorhydria, in white populations from Poland and Scotland (8). Their results contained data that IL1B -511 C>T polymorphism was associated with risk of gastric cancer. While explaining this, they addressed that there were no differences in binding activity between IL1B -511 genotypes, indicating that the effect of IL1B -511 polymorphism may be mediated by linkage disequilibrium with the TATA box polymorphism. This may be possible explanation of our finding, no genedosage relationship between -511 genotypes. In consistence with our data, another recent study reported that IL1B -511 CT heterozygous genotype was the main risk of intestinal type gastric cancer in Korean population (9).
###end p 20
###begin p 21
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Since our results is the first report about the association between IL1B -511 C>T polymorphism and the risk of cervical cancer, we could not compare our results with other data. However, there were several previous reports suggesting the possible association between cervical cancer risk and the polymorphism of other cytokines or cytokine receptors, such as TNF-alpha, interleukin 10, and interleukin 1 receptor antagonist (16-21). Therefore, it can be speculated that functional variation of inflammatory cytokine may influence on the individual susceptibility of cervical cancer.
###end p 21
###begin p 22
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 166 169 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 787 796 784 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL-2/BAX</italic>
###xml 807 809 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 877 880 871 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 41 44 <span type="species:ncbi:10566">HPV</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 286 290 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 960 963 <span type="species:ncbi:10566">HPV</span>
###xml 1008 1011 <span type="species:ncbi:10566">HPV</span>
Degradation of the p53 gene by oncogenic HPV E6 protein is the most well known carcinogenic mechanism in human cervical cancer. Recent findings indicate an increased p53 mutation load or altered p53 protein function in a number of inflammatory diseases (22). It has been shown that, in rats, intratracheal instillation of IL-1 caused hydrogen peroxide production in lung tissue, initiated neutrophil influx and stimulated their release of reactive oxygen species (23). Therefore, it can be speculated that reactive free radicals produced by inflammatory cells may cause DNA damage in epithelial cells. Inflammatory cytokines have also been shown to induce DNA damage and inhibit DNA repair in vitro (24). In addition, IL-1beta has been shown to reduce apoptosis by changing the ratio of BCL-2/BAX proteins (25). Therefore, a higher production of IL-1beta may lead to increased p53 mutation load, and the increased level of IL-1beta may play a role not only in HPV-related cervical carcinogenesis but also in HPV-non-related cervical carcinogenesis.
###end p 22
###begin p 23
###xml 543 547 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
The limitations of the present study are as follows. First, the present study is hospital-based and retrospective in nature. Therefore, it cannot be free from any selection bias. Second, our sample size is so limited that it has not enough statistical power to exclude the existence of gene-dosage relationship. Third, the various epidemiologic risk factors of cervical cancer, such as smoking, alcohol intake, diet, or sexual behavior, were not included for analysis. Fourth, since our study did not include all clustered polymorphic site of IL1B and associated genes, the haplotype analysis could not be done. So, it would be worthwhile to perform further large-scale population-based study including the analysis of various clustered polymorphisms. It also should be noted that the risk of cancer caused by foreign pathogen such as virus or bacteria was repeatedly reported by numerous study (8, 26). Therefore, it can be speculated that increased IL-1beta production may be associated with host genetic factor defending from foreign carcinogenic pathogen.
###end p 23
###begin p 24
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
In conclusion, in Korean population, IL1B -511 CC genotype was significantly associated with decreased risk of cervical cancer. This relationship supports the idea that polymorphism of inflammatory response genes may be host genetic susceptibility to cervical cancer. IL1B polymorphism should be considered as candidate genetic factor in future study elucidating the genetic risk of cervical cancer.
###end p 24
###begin title 25
ACKNOWLEDGEMENT
###end title 25
###begin p 26
The authors wish to thank Dr. Yookyung Lee for manuscript preparation.
###end p 26
###begin p 27
###xml 79 126 79 126 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ministry of Health &amp; Welfare, Republic of Korea</funding-source>
###xml 128 147 128 147 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0412-CR01-0704-0001</award-id>
###xml 197 222 197 222 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Seoul National University</funding-source>
###xml 224 233 224 233 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRI-06-03</award-id>
This study was supported partly by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (0412-CR01-0704-0001) and partly by grant from the CRI Research Fund, Seoul National University (CRI-06-03).
###end p 27
###begin article-title 28
Estimates of the world-wide prevalence of cancer for 25 sites in the adult population
###end article-title 28
###begin article-title 29
Papillomaviruses and cancer: from basic studies to clinical application
###end article-title 29
###begin article-title 30
Inflammation and cancer
###end article-title 30
###begin article-title 31
###xml 78 83 <span type="species:ncbi:9606">women</span>
###xml 108 128 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 130 133 <span type="species:ncbi:10566">HPV</span>
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)
###end article-title 31
###begin article-title 32
###xml 28 48 <span type="species:ncbi:10566">human papillomavirus</span>
Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
###end article-title 32
###begin article-title 33
Effect of concurrent lower genital tract infections on cervical cancer screening
###end article-title 33
###begin article-title 34
Evolution of interleukin-1beta
###end article-title 34
###begin article-title 35
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
###end article-title 35
###begin article-title 36
Novel interleukin 1 beta polymorphism increased the risk of gastric cancer in a Korean population
###end article-title 36
###begin article-title 37
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma
###end article-title 37
###begin article-title 38
Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer
###end article-title 38
###begin article-title 39
An association between LSIL and the high secretor phenotype of IL-1beta
###end article-title 39
###begin article-title 40
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia
###end article-title 40
###begin article-title 41
Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein
###end article-title 41
###begin article-title 42
Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study
###end article-title 42
###begin article-title 43
###xml 73 78 <span type="species:ncbi:9606">women</span>
Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women
###end article-title 43
###begin article-title 44
Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production
###end article-title 44
###begin article-title 45
###xml 59 64 <span type="species:ncbi:9606">women</span>
Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer
###end article-title 45
###begin article-title 46
Polymorphism at the -308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer
###end article-title 46
###begin article-title 47
###xml 37 40 <span type="species:ncbi:10566">HPV</span>
TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia
###end article-title 47
###begin article-title 48
###xml 55 78 <span type="species:ncbi:333760">human papillomavirus 16</span>
TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer
###end article-title 48
###begin article-title 49
Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease
###end article-title 49
###begin article-title 50
###xml 71 75 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally
###end article-title 50
###begin article-title 51
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism
###end article-title 51
###begin article-title 52
Interleukin-1 beta increases the BCL-2/BAX ratio in Kaposi's sarcoma cells
###end article-title 52
###begin article-title 53
###xml 81 98 <span type="species:ncbi:11103">hepatitis C virus</span>
Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection
###end article-title 53
###begin p 54
###xml 65 70 <span type="species:ncbi:9606">women</span>
IL1B -511 polymorphism and the risk of cervical cancer in Korean women
###end p 54
###begin p 55
OR, odds ratio; CI, confidence interval. OR was calculated by logistic regression analysis adjusted for the age.
###end p 55

